跃势生物 (836933.OC)

+ 收藏

现金流量表(跃势生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年中报2018年年报2018年中报2017年年报2017年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 34,209,577.4855,594,554.5626,768,523.2247,797,272.0721,754,705.82
 收到其他与经营活动有关的现金(元) 219,341.574,835,696.132,996,797.206,785,786.673,250,532.16
 经营活动现金流入小计(元) 34,428,919.0560,430,250.6929,765,320.4254,583,058.7425,005,237.98
 购买商品、接受劳务支付的现金(元) 16,355,010.9029,949,718.5414,435,159.7119,727,301.5310,728,289.23
 支付给职工以及为职工支付的现金(元) 6,850,559.287,861,171.153,703,767.886,578,992.972,697,301.59
 支付的各项税费(元) 3,719,064.221,781,280.43495,067.652,011,517.721,825,062.01
 支付其他与经营活动有关的现金(元) 6,325,028.199,516,554.647,432,447.0010,048,791.537,322,265.71
 经营活动现金流出小计(元) 33,249,662.5949,108,724.7626,066,442.2438,366,603.7522,572,918.54
 经营活动产生的现金流量净额(元) 2,179,256.4611,321,525.933,698,878.1816,216,454.992,432,319.44
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,901,347.6413,861,354.0614,562,527.7838,068,286.6516,549,529.88
 投资支付的现金(元) ---2,941,680.00-
 投资活动现金流出小计(元) 1,901,347.6413,861,354.0614,562,527.7841,009,966.6516,549,529.88
 投资活动产生的现金流量净额(元) -1,901,347.64-13,861,354.06-14,562,527.78-41,009,966.65-16,549,529.88
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 4,500,000.0054,350,000.007,330,737.5836,000,000.0019,000,000.00
 收到其他与筹资活动有关的现金(元) -1,030,000.003,303,249.564,870,000.00-
 筹资活动现金流入小计(元) 4,500,000.0055,380,000.0010,633,987.1440,870,000.0019,000,000.00
 偿还债务支付的现金(元) -51,000,000.00-11,000,000.00-
 分配股利、利润或偿付利息支付的现金(元) 1,477,895.022,815,784.231,401,913.731,465,264.78457,523.58
 支付其他与筹资活动有关的现金(元) 1,881,365.131,371,127.53-1,674,416.41-
 筹资活动现金流出小计(元) 3,359,260.1555,186,911.761,401,913.7314,139,681.19457,523.58
 筹资活动产生的现金流量净额(元) 1,140,739.85193,088.249,232,073.4126,730,318.8118,542,476.42
四、汇率变动对现金及现金等价物的影响
五、现金及现金等价物净增加额
 加:期初现金及现金等价物余额(元) 554,364.682,901,104.572,901,104.57964,297.42964,297.42
 期末现金及现金等价物余额(元) 973,013.35554,364.681,269,528.382,901,104.575,389,563.40
补充资料:
 净利润(元) -309,131.85-10,790.70-908,912.582,161,067.59997,857.03
 资产减值准备(元) -124,385.74-41,334.20-
 固定资产和投资性房地产折旧(元) 4,415,411.547,920,652.113,714,908.884,207,976.41832,040.23
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 4,415,411.547,920,652.113,714,908.884,207,976.41832,040.23
 无形资产摊销(元) 8,216.1816,432.366,986.2216,432.448,216.22
 长期待摊费用摊销(元) -48,286.44-122,429.67-
 固定资产报废损失(元) -2,359.08---
 财务费用(元) 1,477,895.022,815,784.231,401,913.731,465,264.78457,523.58
 递延所得税(元) -393,968.54-12,566.6380,353.75-90,582.10-13,883.46
  其中:递延所得税资产减少(元) --12,566.6380,353.75-90,582.10-13,883.46
 递延所得税负债增加(元) -393,968.54----
 存货的减少(元) 98,533.83-3,130,102.84-1,253,619.35902,763.07-494,752.59
 经营性应收项目的减少(元) -767,509.05-584,168.50-12,699,765.94-854,350.36-2,043,794.06
 经营性应付项目的增加(元) -7,779,574.774,131,254.643,513,417.648,244,119.292,061,592.81
 其他(元) 5,429,384.10-9,843,595.83-627,519.68
 现金的期末余额(元) 973,013.35554,364.681,269,528.382,901,104.575,389,563.40
 减:现金的期初余额(元) 554,364.682,901,104.572,901,104.57964,297.42964,297.42
 现金及现金等价物的净增加额(元) 418,648.67-2,346,739.89-1,631,576.191,936,807.154,425,265.98
公告日期 2019-08-282019-04-252018-08-312018-04-272017-08-24
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院